CEO, Innovative Molecules, Florian Vogel said: "With the successful completion of our Phase 1 program, we have achieved a critical development milestone for adibelivir. This validates our clinical ...
MolecuLight today announced that its MolecuLightDX® wound measurement has been qualified by the U.S. Food and Drug Administration (FDA) as a Medical Device Development Tool (MDDT). The FDA's MDDT ...
MolecuLight today announced that its MolecuLightDX wound measurement has been qualified by the U.S. Food and Drug Administration (FDA) as a Medical ...
Opinion
AI's promise, biotech's peril: How unequal access to computing power threatens medical breakthroughs
One way leads to a future in which AI-driven breakthroughs remain the exclusive domain of pharmaceutical giants with billion-dollar budgets. The other, to a landscape where breakthroughs regularly ...
Demeetra AgBio, a genome engineering company enabling research and biomanufacturing through advanced gene-editing technologies and engineered CHO host cells, announced the completion and full ...
Reperio Health and Amazon One Medical today announced a new partnership that connects at-home health screenings with proactive health care. Individuals who complete a Reperio comprehensive preventive ...
New results from a clinical trial co-led by UCLA investigators demonstrate how treating desmoplastic melanoma, a rare and ...
There’s growing awareness of rare, but potentially serious side effects from mega doses of vitamin B6, a nutrient found in supplements and energy drinks.
News-Medical.Net on MSN
Genetic variants associated with rare inherited growth disorder identified in two prehistoric individuals
Researchers led by the University of Vienna and Liège University Hospital Centre have identified genetic variants associated with a rare inherited growth disorder in two prehistoric individuals who ...
Global phase 1/2 clinical trial initiated for GBP511, a vaccine targeting the Sarbecovirus Family Next-generation vaccine ...
DelveInsight's Chronic Hepatitis D Market Insights report includes a comprehensive understanding of current treatment practices, chronic hepatitis D emerging drugs, market share of individual ...
DelveInsight's DUB Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a comprehensive understanding of current treatment practices, addressable patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results